The Office of Research Regulatory Affairs Monitoring Unit is responsible for monitoring all UAMS-sponsored investigator initiated clinical research trials conducted under an Investigational New Drug application (IND) or Investigational Device Exemption (IDE). If your research study requires an Investigational New Drug application or Investigational Device Exemption, this group will work with you to ensure your study is monitored as required by federal regulations (21 CFR 312.56 and 21 CFR 812.40).
Contact the Office of Research Regulatory Affairs Monitoring Unit at ORRAMonitoringUnit@uams.edu.
- Laura Adkins, MAP, CCRP, CCRA, CRS, AdvCRS
Director of ORRA
- Cesiley Trevino, MSHP, CCRP, CRS
Clinical Research Monitoring Manager
- Jennifer Hendrix, BSN, RN
Clinical Research Monitoring Specialist